伊维菌素是首次集体治疗时用于杀灭盘尾丝虫微丝蚴的有效药物。已证明集体单剂量服药就能显著降低皮肤内微丝蚴的水平,持效可达1年之久。伊维菌素治疗的主要目的是降低死亡率。本文报告了在高流行区每6个月集体服用150μg/kg剂量4次后的临床和寄生虫学观察结果,对照组则服用安慰剂。 Ivermectin is the first drug that is used to kill Onchocerciasis microfilaria when first treated collectively. It has been demonstrated that single-dose, single-dose administration can significantly reduce the level of microfilaria in the skin and persist for up to one year. The main purpose of ivermectin treatment is to reduce mortality. This article reports the clinical and parasitic observations of a group taking a dose of 150 μg / kg 4 times every 6 months in a high endemic area, while placebo was given to the control group.